Sai Life Sciences enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
31,676——
12912991.1
95.195.1129
31,642——
−33.8−33.837.5
₹1,494.10——
2,5792,5792,257
3.7%3.7%5.7%
0.00×——
14.06×——
48.07×——
65.49×——
Reference items — trailing FY values
2,2502,1921,695
658631406
483464267
—509314
−83.8−83.8−55.2
—−86.5−68.5
—593369
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SAILIFE₹1,495.70

Sai Life Sciences Ltd.

· Pharma & Health
₹ CrorePeersSYNGENEDIVISLABPPLPHARMANHNEULANDLABNATCOPHARMLALPATHLABCOHANCEMcap ₹31,676 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——31,675.9
- Cash, Equiv & ST Investments91.1128.9128.9
+ Total Debt128.695.195.1
Enterprise Value——31,642.2
Net Debt (memo)37.5-33.8-33.8
EV per Share——1,494.10
Total Capital2,257.02,578.82,578.8
Total Debt/Total Capital5.703.693.69
Total Debt/EV——0.00
EV/Sales——14.06
EV/EBITDA——48.07
EV/EBIT——65.49
Reference Items — Trailing FY Values
Sales1,694.62,192.52,250.4
EBITDA405.7631.2658.2
EBIT267.1464.3483.2
Operating Cash Flow314.0509.1—
Free Cash Flow-55.2-83.8-83.8
FCFF (free cash flow to the firm)-68.5-86.5—
Capital Expenditure369.3593.0—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.